128 related articles for article (PubMed ID: 34620629)
21. Pharmacoepidemiological Research on N-Nitrosodimethylamine-Contaminated Ranitidine Use and Long-Term Cancer Risk: A Population-Based Longitudinal Cohort Study.
Wang CH; Chen II; Chen CH; Tseng YT
Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231768
[TBL] [Abstract][Full Text] [Related]
22. Adverse reactions to H2-receptor antagonists in Denmark before and after transfer of cimetidine and ranitidine to over-the-counter status.
Andersen M; Schou JS
Pharmacol Toxicol; 1991 Oct; 69(4):253-8. PubMed ID: 1683484
[TBL] [Abstract][Full Text] [Related]
23. [Asystole after intravenous administration of ranitidine].
Ferreira TA; Pensado A; Rama P; Molins N; Valdés C; Pose P
Rev Esp Anestesiol Reanim; 1998 Jan; 45(1):30. PubMed ID: 9558936
[No Abstract] [Full Text] [Related]
24. Anaphylaxis following intravenous ranitidine: a rare adverse reaction of a common drug.
Chopra D; Arora P; Khan S; Dwivedi S
Indian J Pharmacol; 2014; 46(2):234-6. PubMed ID: 24741203
[TBL] [Abstract][Full Text] [Related]
25. Comparative risk of Clostridium difficile infection between proton pump inhibitors and histamine-2 receptor antagonists: A 15-year hospital cohort study using a common data model.
Seo SI; You SC; Park CH; Kim TJ; Ko YS; Kim Y; Yoo JJ; Kim J; Shin WG
J Gastroenterol Hepatol; 2020 Aug; 35(8):1325-1330. PubMed ID: 31970824
[TBL] [Abstract][Full Text] [Related]
26. The use of intravenous H2-receptor antagonists in a tertiary care hospital.
Dettmer RM; Riley TH; Byfield F; Green PH
Am J Gastroenterol; 1999 Dec; 94(12):3473-7. PubMed ID: 10606306
[TBL] [Abstract][Full Text] [Related]
27. Effect of Ranitidine Intake on the Risk of Gastric Cancer Development.
Kim S; Lee S; Hong J; Ko I; Kim JY; Kim DK
Healthcare (Basel); 2021 Aug; 9(8):. PubMed ID: 34442208
[TBL] [Abstract][Full Text] [Related]
28. No Increase in Risk of Acute Myocardial Infarction in Privately Insured Adults Prescribed Proton Pump Inhibitors vs Histamine-2 Receptor Antagonists (2002-2014).
Landi SN; Sandler RS; Pate V; Lund JL
Gastroenterology; 2018 Mar; 154(4):861-873.e6. PubMed ID: 29122546
[TBL] [Abstract][Full Text] [Related]
29. Histamine-2 receptor antagonists and risk of lung cancer in diabetic patients – an exploratory analysis.
Hsu CL; Chang CH; Lin JW; Wu LC; Chuang LM; Lai MS
Pharmacoepidemiol Drug Saf; 2013 Jun; 22(6):632-40. PubMed ID: 23576472
[TBL] [Abstract][Full Text] [Related]
30. [Extreme bradycardia and administration of ranitidine].
Velasco P; Armengol S; Rodríguez G; Xirgu J; Pardo C; Oms M
Gastroenterol Hepatol; 1996 Mar; 19(3):186. PubMed ID: 8991668
[No Abstract] [Full Text] [Related]
31. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis.
Lin PC; Chang CH; Hsu PI; Tseng PL; Huang YB
Crit Care Med; 2010 Apr; 38(4):1197-205. PubMed ID: 20173630
[TBL] [Abstract][Full Text] [Related]
32. Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden.
Brusselaers N; Wahlin K; Engstrand L; Lagergren J
BMJ Open; 2017 Oct; 7(10):e017739. PubMed ID: 29084798
[TBL] [Abstract][Full Text] [Related]
33. Acid suppressants use and the risk of dementia: A population-based propensity score-matched cohort study.
Wu CL; Lei WY; Wang JS; Lin CE; Chen CL; Wen SH
PLoS One; 2020; 15(11):e0242975. PubMed ID: 33253311
[TBL] [Abstract][Full Text] [Related]
34. Prenatal exposure to acid-suppressive drugs and the risk of childhood asthma: a population-based Danish cohort study.
Andersen AB; Erichsen R; Farkas DK; Mehnert F; Ehrenstein V; Sørensen HT
Aliment Pharmacol Ther; 2012 May; 35(10):1190-8. PubMed ID: 22443179
[TBL] [Abstract][Full Text] [Related]
35. Fatal anaphylaxis of ranitidine injection : have we not learnt the lesson yet?
Chuah YY; Lee YY; Lin LF; Kuo CJ
Acta Gastroenterol Belg; 2019; 82(3):449-450. PubMed ID: 31566338
[No Abstract] [Full Text] [Related]
36. A multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazole-based triple therapy for the eradication of Helicobacter pylori in dyspeptic patients.
Avşar E; Tiftikçi A; Poturoğlu S; Erzin Y; Kocakaya O; Dinçer D; Yıldırım B; Güliter S; Türkay C; Yılmaz U; Onuk MD; Bölükbaş C; Ellidokuz E; Bektaş A; Taşan G; Aytuğ N; Ateş Y; Kaymakoğlu S
Turk J Gastroenterol; 2013; 24(4):316-21. PubMed ID: 24254262
[TBL] [Abstract][Full Text] [Related]
37. [Pharmaceutical prescription of proton pump inhibitors and ranitidine in the general population living in the area of the Healthcare Authority and University of Udine (Friuli Venezia Giulia, Northeastern Italy)].
Valent F; Deroma L; Lattuada L; Calligaris L; Canciani L
Epidemiol Prev; 2018; 42(5-6):308-315. PubMed ID: 30370732
[TBL] [Abstract][Full Text] [Related]
38. Risk of gastric cancer, gastrointestinal cancers and other cancers: a comparison of treatment with pantoprazole and other proton pump inhibitors.
Schneider JL; Kolitsopoulos F; Corley DA
Aliment Pharmacol Ther; 2016 Jan; 43(1):73-82. PubMed ID: 26541643
[TBL] [Abstract][Full Text] [Related]
39. How often we diagnose allergy to ranitidine?
Bocșan IC; Sabin O; Matei D; Muntean A; Buzoianu AD
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10812-10818. PubMed ID: 33155242
[TBL] [Abstract][Full Text] [Related]
40. Histamine-2 receptor antagonists and gastric cancer.
Johnson AG; Jick SS; Perera DR; Jick H
Epidemiology; 1996 Jul; 7(4):434-6. PubMed ID: 8793372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
